Logo image of BFAM

BRIGHT HORIZONS FAMILY SOLUT (BFAM) Stock Fundamental Analysis

NYSE:BFAM - US1091941005 - Common Stock

116.82 USD
+0.49 (+0.42%)
Last: 9/5/2025, 8:04:00 PM
116.82 USD
0 (0%)
After Hours: 9/5/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BFAM. BFAM was compared to 73 industry peers in the Diversified Consumer Services industry. BFAM has an average financial health and profitability rating. BFAM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BFAM was profitable.
BFAM had a positive operating cash flow in the past year.
BFAM had positive earnings in each of the past 5 years.
BFAM had a positive operating cash flow in each of the past 5 years.
BFAM Yearly Net Income VS EBIT VS OCF VS FCFBFAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

BFAM has a better Return On Assets (4.51%) than 66.67% of its industry peers.
BFAM's Return On Equity of 12.64% is fine compared to the rest of the industry. BFAM outperforms 72.22% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.97%, BFAM is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BFAM is significantly below the industry average of 9.88%.
The last Return On Invested Capital (5.97%) for BFAM is above the 3 year average (4.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.51%
ROE 12.64%
ROIC 5.97%
ROA(3y)2.55%
ROA(5y)2.06%
ROE(3y)8.17%
ROE(5y)6.51%
ROIC(3y)4.2%
ROIC(5y)3.33%
BFAM Yearly ROA, ROE, ROICBFAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 6.34%, BFAM is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
BFAM's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 10.25%, BFAM is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of BFAM has declined.
With a Gross Margin value of 23.67%, BFAM is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BFAM has declined.
Industry RankSector Rank
OM 10.25%
PM (TTM) 6.34%
GM 23.67%
OM growth 3Y8.14%
OM growth 5Y-6.38%
PM growth 3Y9.28%
PM growth 5Y-9.82%
GM growth 3Y-0.82%
GM growth 5Y-1.88%
BFAM Yearly Profit, Operating, Gross MarginsBFAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

4

2. Health

2.1 Basic Checks

BFAM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BFAM has been reduced compared to 1 year ago.
The number of shares outstanding for BFAM has been reduced compared to 5 years ago.
The debt/assets ratio for BFAM has been reduced compared to a year ago.
BFAM Yearly Shares OutstandingBFAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BFAM Yearly Total Debt VS Total AssetsBFAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.72 indicates that BFAM is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.72, BFAM is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of BFAM is 3.70, which is a good value as it means it would take BFAM, 3.70 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.70, BFAM is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
A Debt/Equity ratio of 0.64 indicates that BFAM is somewhat dependend on debt financing.
BFAM has a Debt to Equity ratio (0.64) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 3.7
Altman-Z 2.72
ROIC/WACC0.7
WACC8.55%
BFAM Yearly LT Debt VS Equity VS FCFBFAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.56 indicates that BFAM may have some problems paying its short term obligations.
BFAM has a worse Current ratio (0.56) than 81.94% of its industry peers.
A Quick Ratio of 0.56 indicates that BFAM may have some problems paying its short term obligations.
BFAM's Quick ratio of 0.56 is on the low side compared to the rest of the industry. BFAM is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
BFAM Yearly Current Assets VS Current LiabilitesBFAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.77% over the past year.
Measured over the past years, BFAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.06% on average per year.
Looking at the last year, BFAM shows a quite strong growth in Revenue. The Revenue has grown by 9.24% in the last year.
Measured over the past years, BFAM shows a small growth in Revenue. The Revenue has been growing by 5.43% on average per year.
EPS 1Y (TTM)26.77%
EPS 3Y20.08%
EPS 5Y-1.06%
EPS Q2Q%21.59%
Revenue 1Y (TTM)9.24%
Revenue growth 3Y15.24%
Revenue growth 5Y5.43%
Sales Q2Q%9.18%

3.2 Future

The Earnings Per Share is expected to grow by 18.45% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.65% on average over the next years.
EPS Next Y24.6%
EPS Next 2Y20.23%
EPS Next 3Y18.45%
EPS Next 5YN/A
Revenue Next Year8.37%
Revenue Next 2Y7.74%
Revenue Next 3Y7.65%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BFAM Yearly Revenue VS EstimatesBFAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BFAM Yearly EPS VS EstimatesBFAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.73, BFAM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of BFAM is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.06, BFAM is valued at the same level.
With a Price/Forward Earnings ratio of 23.22, BFAM is valued on the expensive side.
Based on the Price/Forward Earnings ratio, BFAM is valued a bit cheaper than 61.11% of the companies in the same industry.
BFAM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.69.
Industry RankSector Rank
PE 29.73
Fwd PE 23.22
BFAM Price Earnings VS Forward Price EarningsBFAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BFAM's Enterprise Value to EBITDA is on the same level as the industry average.
62.50% of the companies in the same industry are more expensive than BFAM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.37
EV/EBITDA 19.27
BFAM Per share dataBFAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BFAM's earnings are expected to grow with 18.45% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y20.23%
EPS Next 3Y18.45%

0

5. Dividend

5.1 Amount

No dividends for BFAM!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHT HORIZONS FAMILY SOLUT

NYSE:BFAM (9/5/2025, 8:04:00 PM)

After market: 116.82 0 (0%)

116.82

+0.49 (+0.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners104.39%
Inst Owner Change-0.62%
Ins Owners1.04%
Ins Owner Change-0.47%
Market Cap6.64B
Analysts75
Price Target139.91 (19.77%)
Short Float %1.31%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.49%
Min EPS beat(2)3.82%
Max EPS beat(2)17.16%
EPS beat(4)4
Avg EPS beat(4)7.34%
Min EPS beat(4)2.44%
Max EPS beat(4)17.16%
EPS beat(8)8
Avg EPS beat(8)9.2%
EPS beat(12)11
Avg EPS beat(12)8.49%
EPS beat(16)13
Avg EPS beat(16)7.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)-0.98%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)-0.98%
Revenue beat(8)2
Avg Revenue beat(8)-0.48%
Revenue beat(12)5
Avg Revenue beat(12)-0.04%
Revenue beat(16)5
Avg Revenue beat(16)-1.32%
PT rev (1m)-0.4%
PT rev (3m)-1.04%
EPS NQ rev (1m)6.32%
EPS NQ rev (3m)1.83%
EPS NY rev (1m)3.31%
EPS NY rev (3m)3.42%
Revenue NQ rev (1m)0.78%
Revenue NQ rev (3m)1.07%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 29.73
Fwd PE 23.22
P/S 2.38
P/FCF 27.37
P/OCF 20.01
P/B 4.75
P/tB N/A
EV/EBITDA 19.27
EPS(TTM)3.93
EY3.36%
EPS(NY)5.03
Fwd EY4.31%
FCF(TTM)4.27
FCFY3.65%
OCF(TTM)5.84
OCFY5%
SpS49.07
BVpS24.6
TBVpS-10.93
PEG (NY)1.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.51%
ROE 12.64%
ROCE 9.28%
ROIC 5.97%
ROICexc 6.33%
ROICexgc 19.34%
OM 10.25%
PM (TTM) 6.34%
GM 23.67%
FCFM 8.7%
ROA(3y)2.55%
ROA(5y)2.06%
ROE(3y)8.17%
ROE(5y)6.51%
ROIC(3y)4.2%
ROIC(5y)3.33%
ROICexc(3y)4.34%
ROICexc(5y)3.5%
ROICexgc(3y)12.8%
ROICexgc(5y)10.08%
ROCE(3y)6.38%
ROCE(5y)5.04%
ROICexcg growth 3Y25.15%
ROICexcg growth 5Y0.54%
ROICexc growth 3Y21.52%
ROICexc growth 5Y-2.3%
OM growth 3Y8.14%
OM growth 5Y-6.38%
PM growth 3Y9.28%
PM growth 5Y-9.82%
GM growth 3Y-0.82%
GM growth 5Y-1.88%
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 3.7
Debt/EBITDA 2.39
Cap/Depr 99.9%
Cap/Sales 3.2%
Interest Coverage 4.46
Cash Conversion 88.47%
Profit Quality 137.26%
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z 2.72
F-Score9
WACC8.55%
ROIC/WACC0.7
Cap/Depr(3y)82.72%
Cap/Depr(5y)76.47%
Cap/Sales(3y)3.63%
Cap/Sales(5y)4.02%
Profit Quality(3y)180.37%
Profit Quality(5y)247.75%
High Growth Momentum
Growth
EPS 1Y (TTM)26.77%
EPS 3Y20.08%
EPS 5Y-1.06%
EPS Q2Q%21.59%
EPS Next Y24.6%
EPS Next 2Y20.23%
EPS Next 3Y18.45%
EPS Next 5YN/A
Revenue 1Y (TTM)9.24%
Revenue growth 3Y15.24%
Revenue growth 5Y5.43%
Sales Q2Q%9.18%
Revenue Next Year8.37%
Revenue Next 2Y7.74%
Revenue Next 3Y7.65%
Revenue Next 5YN/A
EBIT growth 1Y40.15%
EBIT growth 3Y24.62%
EBIT growth 5Y-1.3%
EBIT Next Year73.11%
EBIT Next 3Y29.57%
EBIT Next 5YN/A
FCF growth 1Y53.44%
FCF growth 3Y13.6%
FCF growth 5Y1.9%
OCF growth 1Y36.83%
OCF growth 3Y14.08%
OCF growth 5Y0.42%